Follow Us
© 2026 Arizent. All rights reserved.
Employers are spending more on GLP-1s than ever before, and I believe many of them are actually paying for weight gain.
GLP-1s have kicked employer healthcare spending into overdrive, with many reporting that covering GLP-1s had a “significant” impact on the health plan’s prescription drug spending. Some are willing to pay the price, betting that treating obesity now avoids the higher costs of managing diabetes, hypertension and musculoskeletal conditions down the line.
For reprint and licensing requests for this article, click here.
Today's complex stressors require clearer access pathways and a company-wide commitment to mental health support.
Open enrollment doesn’t have to overwhelm employees. Collective Health’s Jacque Ludwig shares how employers can drive engagement and make benefits easier to navigate.
MetLife’s president of U.S. business shares why improving employees’ benefits literacy results in them making smarter choices for their health and financial wellness.
As artificial intelligence continues to move into the mainstream, opportunities abound for eliminating confusion, personalizing content and improving outcomes.
Employers face another steep rise in healthcare expenses in 2027, prompting a closer look at GLP-1 coverage, pharmacy spending and high-cost conditions.
